BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 27349145)

  • 21. The chloroform extract of Cyclocarya paliurus attenuates high-fat diet induced non-alcoholic hepatic steatosis in Sprague Dawley rats.
    Lin Z; Wu ZF; Jiang CH; Zhang QW; Ouyang S; Che CT; Zhang J; Yin ZQ
    Phytomedicine; 2016 Nov; 23(12):1475-1483. PubMed ID: 27765368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway.
    Yao H; Tao X; Xu L; Qi Y; Yin L; Han X; Xu Y; Zheng L; Peng J
    Pharmacol Res; 2018 May; 131():51-60. PubMed ID: 29574225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human HepG2 cells and obese mice.
    Hwang YP; Choi JH; Han EH; Kim HG; Wee JH; Jung KO; Jung KH; Kwon KI; Jeong TC; Chung YC; Jeong HG
    Nutr Res; 2011 Dec; 31(12):896-906. PubMed ID: 22153515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice.
    Inamdar S; Joshi A; Malik S; Boppana R; Ghaskadbi S
    Biochem Biophys Res Commun; 2019 Oct; 519(1):106-112. PubMed ID: 31472955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models.
    Zhang Y; Meng T; Zuo L; Bei Y; Zhang Q; Su Z; Huang Y; Pang J; Xiang Q; Yang H
    Mar Drugs; 2017 Jun; 15(6):. PubMed ID: 28587208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melatonin Modulates lipid Metabolism in HepG2 Cells Cultured in High Concentrations of Oleic Acid: AMPK Pathway Activation may Play an Important Role.
    Mi Y; Tan D; He Y; Zhou X; Zhou Q; Ji S
    Cell Biochem Biophys; 2018 Dec; 76(4):463-470. PubMed ID: 30324559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
    López-Oliva ME; Garcimartin A; Muñoz-Martínez E
    Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deoxypodophyllotoxin in Anthriscus sylvestris alleviates fat accumulation in the liver via AMP-activated protein kinase, impeding SREBP-1c signal.
    Kim KY; Park KI; Lee SG; Baek SY; Lee EH; Kim SC; Kim SH; Park SG; Yu SN; Oh TW; Kim JH; Kim KJ; Ahn SC; Kim YW
    Chem Biol Interact; 2018 Oct; 294():151-157. PubMed ID: 30148990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
    Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice.
    Zhang C; Chen X; Zhu RM; Zhang Y; Yu T; Wang H; Zhao H; Zhao M; Ji YL; Chen YH; Meng XH; Wei W; Xu DX
    Toxicol Lett; 2012 Aug; 212(3):229-40. PubMed ID: 22698815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation.
    Lelliott CJ; Ljungberg A; Ahnmark A; William-Olsson L; Ekroos K; Elmgren A; Arnerup G; Shoulders CC; Oscarsson J; Lindén D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2707-13. PubMed ID: 17932310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of new thiazolidine derivatives LPSF/GQ-02 and LPSF/GQ-16 on atherosclerotic lesions in LDL receptor-deficient mice (LDLR(-/-)).
    Soares E Silva AK; de Oliveira Cipriano Torres D; Santos Rocha SW; dos Santos Gomes FO; dos Santos Silva B; Donato MA; Raposo C; Santos AC; de Lima Mdo C; Galdino SL; da Rocha Pitta I; de Souza JR; Peixoto CA
    Cardiovasc Pathol; 2013; 22(1):81-90. PubMed ID: 22795892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
    Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioactive Peptide Improves Diet-Induced Hepatic Fat Deposition and Hepatocyte Proinflammatory Response in SAMP8 Ageing Mice.
    Dumeus S; Shibu MA; Lin WT; Wang MF; Lai CH; Shen CY; Lin YM; Viswanadha VP; Kuo WW; Huang CY
    Cell Physiol Biochem; 2018; 48(5):1942-1952. PubMed ID: 30092591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
    Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
    Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheum palmatum L. Attenuates High Fat Diet-Induced Hepatosteatosis by Activating AMP-Activated Protein Kinase.
    Yang M; Li X; Zeng X; Ou Z; Xue M; Gao D; Liu S; Li X; Yang S
    Am J Chin Med; 2016; 44(3):551-64. PubMed ID: 27109162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat-Killed
    Lee JH; Woo KJ; Hong J; Han KI; Kim HS; Kim TJ
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.